Results 91 to 100 of about 1,795 (145)

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients. [PDF]

J Clin Med
Tamaki S, Wada H, Shinke N, Nishiki J, Sasao R, Fujieda A, Matsumoto T, Tawara I, Hashiguchi T.   +8 more
europepmc   +1 more source

The Global Gap in the Hemophilia Paradigm Shift: Disparities in Research, Care, and Musculoskeletal Health. [PDF]

Hematol Rep
Querol-Giner F, Querol-Giner M, Chimeno-Hernández A, Alberola-Zorrilla P, Pérez-Alenda S, Bonanad S, Querol-Fuentes F.   +6 more
europepmc   +1 more source

Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab. [PDF]

J Mark Access Health Policy
Sugg Herrera D, Sepúlveda Viveros D, Russo Namias M, Garrido N.   +3 more
europepmc   +1 more source

Severe hemophilia A with inhibitors and pancreatic cancer - when emicizumab is not enough. [PDF]

Blood Transfus
Biglietto M, Linari S, Faccini AL, Sorella S, Crisanti E, Antonacci M, Ligia S, Mormile R, Ciciani R, Baldacci E, Santoro C.   +10 more
europepmc   +1 more source

Biologics and Drug-Induced Immunogenicity: A Case Report of Acquired Hemophilia A Presenting After Immunotherapy. [PDF]

Clin Case Rep
Murgas KA, Nasim S, Poos S, Cohen JA, Andrzejczyk A.   +4 more
europepmc   +1 more source

NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.

Blood
Nogami K, You CW, Park YS, Chen YC, Shen MC, Wang JD, Takeyama M, Amano K, Chou SC, Miwa T, Chen CA, Miyake T, Iwasaki K, Kobayashi R, Shima M.   +14 more
europepmc   +1 more source

Predicting Recovery After Joint Bleeding in Persons With Bleeding Disorders. [PDF]

Haemophilia
Aertssen G, van Vulpen LFD, Foppen W, van Leeuwen FHP, Timmer MA.   +4 more
europepmc   +1 more source

Outcomes of Emicizumab Treatment for Haemophilia A Paediatric Patients: A Systematic Review With Meta-Analysis. [PDF]

Haemophilia
Bolou K, Triantafyllou G, Dettoraki A, Michalopoulou A, Kyprianou M, Papakonstantinou O, Pergantou H.   +6 more
europepmc   +1 more source

Massive Intra-Abdominal Pseudotumor in a Patient With Hemophilia A Treated With Emicizumab: A Case Report. [PDF]

Clin Case Rep
Kilach CJ, Njuguna C, Njuguna F, Wanjiku CM, Molitor KF, Janson IA, Mbunya SM, Shapiro AD, Sagar J, Greist A.   +9 more
europepmc   +1 more source

Emicizumab in infants: not just cost-effective but mandatory. [PDF]

Blood Adv
Young G.
europepmc   +1 more source